CagriSema vs Tirzepatide: 23% Weight Loss in Phase 3 Trial US$ 23.07 Min. order: 1 piece ★★★★★ 4.1 (162 reviews) Sold : Login>>
GLP-1 Receptor Agonist Market Size, Share US$ 25.50 Min. order: 1 piece ★★★★★ 4.6 (172 reviews) Sold : Login>>
Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination US$ 20.17 Min. order: 1 piece ★★★★★ 4.6 (178 reviews) Sold : Login>>
Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants - Gabe - 2024 - Diabetes, Obesity and Metabolism US$ 21.78 Min. order: 1 piece ★★★★★ 4.0 (204 reviews) Sold : Login>>